Saskatoon City Hospital is a public hospital in the City Park neighbourhood of Saskatoon, Saskatchewan, Canada. It was opened in 1909 and was the second municipal hospital in Canada. The hospital moved to its current location in 1993. The hospital is operated by the Saskatchewan Health Authority.

During the past decade, Saskatoon City Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saskatoon City Hospital" #1 sponsor was "University of Saskatchewan" with 6 trials, followed by "Pfizer" with 3 trials sponsored, "Cytokinetics" with 2 trials sponsored, "Anthony Magliocco" with 1 trials sponsored and "Bausch & Lomb Incorporated" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saskatoon City Hospital" #1 collaborator was "Saskatoon Health Region" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Canadian Critical Care Trials Group" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "DHR Health Institute for Research and Development" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Saskatoon City Hospital" are "Ulcerative Colitis" (3 trials), "Amyotrophic Lateral Sclerosis" (2 trials), "ALS" (1 trials), "Alzheimer Disease" (1 trials) and "Any Patient Who Fulfills the Inclusion Criteria to be Implanted With a Dual Chamber Pacemaker Maybe Included in the Study as Per ACC/AHA Guidelines" (1 trials). Many other conditions were trialed in "Saskatoon City Hospital" in a lesser frequency.

Most popular intervention types in "Saskatoon City Hospital" are "Drug" (13 trials), "Procedure" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "CP-690,550" (2 trials), "Reldesemtiv" (2 trials), ".2% Ropivacaine" (1 trials) and "ASM8" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saskatoon City Hospital" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Saskatoon City Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Saskatoon City Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saskatoon City Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".